Skip to Content

Can a PDE4-inhibitor be the next approved drug for the treatment of hidradenitis suppurativa?

In this MEDtalk, Elisabeth H. Taudorf, MD, Zealand University Hospital takes a deep dive into a patient case with severe HS. The patient was treated with a PDE-4 inhibitor. In this phase-II study, the focus was on reduced pain and increased quality of life following treatment with the pde4-inhibitor.

Elisabeth Hjardem Taudorf

Få tillgång till artikeln

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top